Dr. Kaarina Kowalec News Archive
July 4, 2023 —
Research aims to provide early interventions and improve mental and physical health outcomes for MS patients.
March 28, 2023 —
Winning the oral presentation category at the College of Pharmacy’s Research Day showed PhD student Dr. Laila Aboulatta that she’s on the right track with her PhD project.
October 28, 2022 —
Electroconvulsive therapy (ECT) is a treatment reserved for the most severe cases of depression, bipolar disorder and schizophrenia. Positive results are not guaranteed. Could genetic insight in the form of a patient’s “polygenic risk score” help to predict whether electroconvulsive therapy will be effective for that patient?
March 1, 2021 —
A UM team is starting a novel study to see if our cautionary measures are enabling a disaster somewhere else
March 17, 2020 —
A new study published last month in the Oxford University Press Inflammatory Bowel Diseases journal has found that one in six persons with inflammatory bowel disease (IBD) experience a substance use disorder in their lifetime.
November 13, 2019 —
A high proportion of those with schizophrenia are not responsive to treatment, placing them at higher risk for mortality and suicide, compared to people with schizophrenia who respond to treatment